RHUMBLINE ADVISERS

Position in AVBP — ArriVent BioPharma, Inc.

CIK 1115418 BOSTON, MA

Position in AVBP

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,606,863

+$795,999 QoQ

Shares Held

46,254

+31.6% QoQ

Ownership

0.094%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#57

of 158 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 22% Shared 0% None 78%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. AVBP ranks #112 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,606,863	46,254	+31.6%	Shares	Sole	2026-08-12
2026-03-31	$810,864	35,148	+11.7%	Shares	Sole	2026-05-12
2025-12-31	$632,894	31,456	-6.9%	Shares	Sole	2026-02-13
2025-09-30	$623,665	33,803	-0.4%	Shares	Sole	2025-11-06
2025-06-30	$739,178	33,954	-8.6%	Shares	Sole	2025-08-12
2025-03-31	$686,774	37,143	+1.2%	Shares	Sole	2025-05-29
2024-12-31	$977,421	36,690	+9.1%	Shares	Sole	2025-05-29
2024-09-30	$790,093	33,621	+164.6%	Shares	Sole	2024-11-12
2024-06-30	$235,714	12,707	+30.1%	Shares	Sole	2024-08-01
2024-03-31	$174,402	9,765	—	Shares	Sole	2024-05-09
No filing history on record for this holder in this stock.